ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,302 JPY | -1.67% |
|
+8.74% | +29.04% |
ETFs positioned on ASKA Pharmaceutical Holdings Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 19 M€ | +11.47% | ||
| 0.01% | 17 M€ | +11.76% | - | |
| 0.00% | 140,441 M€ | +16.85% | ||
| 0.00% | 63,295 M€ | +16.94% | - | |
| 0.00% | 20,360 M€ | +15.77% | - |
ASKA Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
Sector
Pharmaceuticals
Calendar
05/08/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2,302
JPY
Average target price
2,733
JPY
Spread / Average Target
+18.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.04% | 43Cr | |
| +32.85% | 71TCr | |
| +30.77% | 60TCr | |
| -1.75% | 37TCr | |
| +20.18% | 33TCr | |
| +5.99% | 29TCr | |
| +14.77% | 24TCr | |
| +9.13% | 21TCr | |
| -3.97% | 20TCr | |
| +9.39% | 17TCr |
- Stock Market
- Equities
- 4886 Stock
- Funds and ETFs ASKA Pharmaceutical Holdings Co.,Ltd.